SCHEMBL30844326

SCHEMBL30844326

CC(C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)O

nearest known ligand 0.48

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ F2 P00734 2/20 0.48
▸ CTSD P07339 1/20 0.46
▸ BACE1 P56817 1/20 0.46
▸ CALCRL Q16602 2/20 0.45
▸ NTSR2 O95665 4/20 0.45
▸ NTSR1 P30989 4/20 0.45
▸ SORT1 Q99523 4/20 0.45
▸ GRB2 P62993 1/20 0.44
▸ NRP1 O14786 1/20 0.42
▸ NPY2R P49146 4/20 0.42
▸ NPY4R P50391 4/20 0.42
▸ NPY5R Q15761 4/20 0.42
▸ NPY1R P25929 3/20 0.42
▸ XIAP P98170 1/20 0.41
▸ OPRM1 P35372 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30844325 0.96 F2 (0.49) F2CTSDBACE1CALCRLNTSR2
SCHEMBL30844352 0.96 F2 (0.49) F2CTSDBACE1CALCRLNTSR2
SCHEMBL30844320 0.96 F2 (0.49) F2CTSDBACE1CALCRLNTSR2
SCHEMBL30844288 0.96 F2 (0.49) F2CTSDBACE1CALCRLNTSR2
SCHEMBL30844305 0.96 F2 (0.49) F2CTSDBACE1CALCRLNTSR2
SCHEMBL30844281 0.96 F2 (0.49) F2CTSDBACE1CALCRLNTSR2
SCHEMBL30844330 0.96 F2 (0.49) F2CTSDBACE1CALCRLNTSR2
SCHEMBL30844246 0.96 F2 (0.49) F2CTSDBACE1CALCRLNTSR2
SCHEMBL30844365 0.94 F2 (0.47) F2NPY2RNPY4RNPY5RNPY1R
SCHEMBL30844319 0.93 F2 (0.49) F2CALCRLNTSR2NTSR1SORT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250101063-A1 POLYPEPTIDE COMPOUND AND USE THEREOF IN TREATMENT OF ENTERITIS SICHUAN GOODDOCTOR PANXI PHARMACEUTICAL CO., LTD. (CN) 2025-03-27 — — US claimed
EP-4467562-A1 POLYPEPTIDE COMPOUND AND USE THEREOF IN TREATMENT OF ENTERITIS Sichuan Gooddoctor Panxi Pharmaceutical Co. Ltd (CN) 2024-11-27 — — EP claimed
CN-117858890-A Polypeptide compound and application thereof in treating enteritis 四川好医生攀西药业有限责任公司 2024-04-09 — — CN claimed
US-20250101063-A1 POLYPEPTIDE COMPOUND AND USE THEREOF IN TREATMENT OF ENTERITIS SICHUAN GOODDOCTOR PANXI PHARMACEUTICAL CO., LTD. (CN) 2025-03-27 — — US disclosed
EP-4467562-A1 POLYPEPTIDE COMPOUND AND USE THEREOF IN TREATMENT OF ENTERITIS Sichuan Gooddoctor Panxi Pharmaceutical Co. Ltd (CN) 2024-11-27 — — EP disclosed
CN-117858890-A Polypeptide compound and application thereof in treating enteritis 四川好医生攀西药业有限责任公司 2024-04-09 — — CN disclosed
Send feedback